Literature DB >> 26482906

Limited effect of mild therapeutic hypothermia on outcome after prolonged resuscitation.

Christian Wallmüller1, Christoph Testori2, Fritz Sterz1, Peter Stratil1, Andreas Schober1, Harald Herkner1, Pia Hubner1, Christoph Weiser1, Mathias Stöckl1, Andrea Zeiner1, Heidrun Losert1.   

Abstract

BACKGROUND: Mild therapeutic hypothermia interferes with multiple cascades of the ischaemia/reperfusion injury that is known as primary mechanism for brain damage after cardiac arrest. First resuscitation attempts and the duration of resuscitation efforts will initiate and aggravate this pathophysiology. Therefore we investigated the interaction between the duration of basic and advanced life support and outcome after cardiac arrest in patients treated with or without mild therapeutic hypothermia.
METHODS: This retrospective cohort study included patients 18 years of age or older suffering a witnessed out-of-hospital cardiac arrest with presumed cardiac cause, which remained comatose after restoration of spontaneous circulation. The basic and advanced life support 'low-flow' time, categorized into four quartiles (0-11, 12-17, 18-28, ≥ 29 min), was correlated with neurological outcome.
RESULTS: Out of 1103 patients 613 were cooled to a target temperature of 33 ± 1 °C for 24h. In the three quartiles with 'low-flow' time up to 28 min cooling was associated with >2-fold odds of favourable neurological outcome. In the fourth quartile with 'low-flow' time of ≥ 29 min cooling had no influence on neurological outcome (OR: 0.73; 95% CI: 0.38-1.4, test for interaction p<0.01).
CONCLUSION: The duration of resuscitation efforts, defined as 'low-flow' time, influences the effectiveness of mild therapeutic hypothermia in terms of neurologic outcome. Patients with low to moderate 'low-flow' time benefit most from this treatment.
Copyright © 2015 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Cardiopulmonary resuscitation; Induced mild hypothermia; Out-of-hospital cardiac arrest; Reperfusion injury

Mesh:

Year:  2015        PMID: 26482906     DOI: 10.1016/j.resuscitation.2015.09.400

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  5 in total

1.  Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest: The CAPITAL CHILL Randomized Clinical Trial.

Authors:  Michel Le May; Christina Osborne; Juan Russo; Derek So; Aun Yeong Chong; Alexander Dick; Michael Froeschl; Christopher Glover; Benjamin Hibbert; Jean-François Marquis; Sophie De Roock; Marino Labinaz; Jordan Bernick; Shawn Marshall; Ronnen Maze; George Wells
Journal:  JAMA       Date:  2021-10-19       Impact factor: 56.272

2.  Validation of the CREST score for predicting circulatory-aetiology death in out-of-hospital cardiac arrest without STEMI.

Authors:  Timothy N Jones; Matthew Kelham; Krishnaraj S Rathod; Charles J Knight; Alastair Proudfoot; Ajay K Jain; Andrew Wragg; Muhiddin Ozkor; Paul Rees; Oliver Guttmann; Andreas Baumbach; Anthony Mathur; Daniel A Jones
Journal:  Am J Cardiovasc Dis       Date:  2021-12-15

Review 3.  Time to Cooling Is Associated with Resuscitation Outcomes.

Authors:  Robert B Schock; Andreas Janata; W Frank Peacock; Nathan S Deal; Sarathi Kalra; Fritz Sterz
Journal:  Ther Hypothermia Temp Manag       Date:  2016-10-19       Impact factor: 1.286

4.  Age-dependent effect of targeted temperature management on outcome after cardiac arrest.

Authors:  Christian Wallmüller; Alexander Spiel; Fritz Sterz; Andreas Schober; Pia Hubner; Peter Stratil; Christoph Testori
Journal:  Eur J Clin Invest       Date:  2018-10-08       Impact factor: 4.686

5.  Comparison of in-hospital and out-of-hospital cardiac arrest patients receiving targeted temperature management: A matched case-control study.

Authors:  Chung-Ting Chen; Cheng-Han Chen; Tzu-Yin Chen; David Hung-Tsang Yen; Chorng-Kuang How; Peter Chuanyi Hou
Journal:  J Chin Med Assoc       Date:  2020-09       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.